DR. GEORGE HARRISON TALBOT, M.D.
Medical Practice at Wayne Ave, Wayne, PA
License number
Pennsylvania MD018740E
Category
Medical Practice
Type
Specialist
Address
Address
133 N Wayne Ave #2, Wayne, PA 19087
Phone
(610) 710-1600
Personal information
See more information about GEORGE HARRISON TALBOT at radaris.comName
Address
Phone
728 Norristown Rd APT D111, Ambler, PA 19002
857 N 23Rd St, Philadelphia, PA 19130
1112 New Hampshire Ln, Downingtown, PA 19335
222 Marshall Ave, Pittsburgh, PA 15214
103 Woodland Rd, Shippenville, PA 16254
Professional information
See more information about GEORGE HARRISON TALBOT at trustoria.com
Dr. George H Talbot, Wayne PA - MD (Doctor of Medicine)
Dr. George H Talbot, Wayne PA - MD (Doctor of Medicine)
Specialties:
Infectious Disease Medicine
Address:
133 N Wayne Ave SUITE 2, Wayne 19087
(610) 710-1600 (Phone)
(610) 710-1600 (Phone)
Certifications:
Infectious Disease, 1986, Internal Medicine, 1978
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Yale University
Graduated: 1975
Philadelphia General Hospital
Pennsylvania Hospital Of University Of Pennsylvania Health System
Hospital Of The University Of Pennsylvania
Yale University
Graduated: 1975
Philadelphia General Hospital
Pennsylvania Hospital Of University Of Pennsylvania Health System
Hospital Of The University Of Pennsylvania
Compositions And Methods For Treating Bacterial Infections Using Ceftaroline
Compositions And Methods For Treating Bacterial Infections Using Ceftaroline
US Patent:
2011007, Mar 24, 2011
Filed:
Sep 21, 2010
Appl. No.:
12/887140
Inventors:
Dirk Thye - San Francisco CA, US
George Talbot - Wayne PA, US
George Talbot - Wayne PA, US
Assignee:
FOREST LABORATORIES HOLDINGS LTD. - Hamilton
International Classification:
A61K 31/675, A61P 31/04
US Classification:
514 80
Abstract:
The present invention relates to compositions comprising ceftaroline or a prodrug thereof (e.g., ceftaroline fosamil) and methods for treating bacterial infections, such as complicated skin and structure infections (cSSSI) and community-acquired bacterial pneumonia (CABP) by administering ceftaroline or a prodrug thereof, (e.g., ceftaroline fosamil).